OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression
Sagar V. Parikh, Jennifer L. Vande Voort, Anastasia K. Yocum, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 143-151
Closed Access | Times Cited: 3
Sagar V. Parikh, Jennifer L. Vande Voort, Anastasia K. Yocum, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 143-151
Closed Access | Times Cited: 3
Showing 3 citing articles:
Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial
Balwinder Singh, Sagar V. Parikh, Jennifer L. Vande Voort, et al.
Psychiatry Research (2024) Vol. 335, pp. 115829-115829
Closed Access | Times Cited: 9
Balwinder Singh, Sagar V. Parikh, Jennifer L. Vande Voort, et al.
Psychiatry Research (2024) Vol. 335, pp. 115829-115829
Closed Access | Times Cited: 9
High baseline plasma anthranilic acid predicts remission upon acute-series ketamine infusion for treatment-resistant depression
Stephen Murata, Zachary Madaj, Colt Capan, et al.
Biological Psychiatry Global Open Science (2025), pp. 100503-100503
Open Access
Stephen Murata, Zachary Madaj, Colt Capan, et al.
Biological Psychiatry Global Open Science (2025), pp. 100503-100503
Open Access
Baseline perceived stress as a predictor of ketamine/esketamine treatment response in treatment-resistant depression
Stefanie Cavalcanti, Vanessa Pazdernik, Jennifer L. Vande Voort, et al.
Journal of Affective Disorders (2025)
Closed Access
Stefanie Cavalcanti, Vanessa Pazdernik, Jennifer L. Vande Voort, et al.
Journal of Affective Disorders (2025)
Closed Access
Intravenous (IV) ketamine versus intranasal esketamine for depression– Advantage IV ketamine?
Balwinder Singh, Simon Kung, Jennifer L. Vande Voort
Journal of Affective Disorders (2024) Vol. 356, pp. 564-567
Closed Access | Times Cited: 3
Balwinder Singh, Simon Kung, Jennifer L. Vande Voort
Journal of Affective Disorders (2024) Vol. 356, pp. 564-567
Closed Access | Times Cited: 3
